Discovery
University of Alabama at Birmingham backed with USD 2.34m NIAID grant for congenital syphilis trial
The University of Alabama at Birmingham has received a USD 2.34 million NIAID U01 cooperative agreement to conduct CONSISTENT, a Phase IV randomized...
Feinstein Institute receives USD 2.6m NIH grant for Alzheimer's disease eCIRP pathway research
The Feinstein Institute for Medical Research in Manhasset, New York, has received a USD 2.6 million NIH RF1 grant from the National Institute on Aging to...
Northwestern University receives USD 1.84m NIH grant for tauopathy gene therapy development
Northwestern University has received a USD 1.84 million NIH RF1 grant from the National Institute of Neurological Disorders and Stroke to advance...
Canadian researchers identify naporafenib-trametinib combo strategy for anaplastic thyroid cancer
Researchers at Western University and London Health Sciences Centre in London, Ontario, Canada, working with collaborators at the Ontario Institute for...
University of Pittsburgh receives USD 2.16m NIAID grant for phage therapy center targeting multidrug-resistant bacteria
The University of Pittsburgh has received a USD 2.16 million NIAID P01 program grant to establish the Pitt Center for Accelerating Phage Therapy (P-CAPT), a...
Quiver Bioscience secures USD 1.99m NIH grant for Nav1.7-targeting antisense oligonucleotide program
Quiver Bioscience, a Cambridge, Massachusetts-based biotech company, has received a USD 1.99 million NIH UG3 award from the National Institute of...
University of Washington backed with USD 1.2m grant to explore impact of diabetes on CVD in the young
The University of Washington has received a USD 1.2 million NHLBI R35 award to investigate how diabetes accelerates cardiovascular disease in youth, with...
Weill Cornell Medicine receives USD 3.8m NIAID grant for HIV-1 vaccine research
Weill Cornell Medicine has received a USD 3.8 million NIAID P01 program project grant to advance germline-targeting HIV-1 vaccine immunogen research, with...
University of Massachusetts Medical School Worcester receives USD 1.675m NIH grant for AAV gene therapy safety research
A safety question at the core of AAV gene therapy is drawing new federal attention, as the University of Massachusetts Medical School Worcester has received...
Seattle Children's Hospital picks up USD 2.1m NIH grant for AI nanobody engineering platform
An AI-driven approach to nanobody engineering is drawing federal support, with Seattle Children's Hospital receiving a USD 2.1 million NIH R01 grant to...
HCW Biologics' fusion immunotherapeutic prevents bronchopulmonary dysplasia in preclinical models
HCW Biologics reports HCW11-040 prevents bronchopulmonary dysplasia in IND-enabling animal studies
Silexion's RNAi therapy shows increased MHC-I surface expression in preclinical models of KRAS-mutated pancreatic cancer
Silexion Therapeutics (Nasdaq: SLXN), a Cayman Islands-based clinical-stage biotechnology company, has reported preclinical data showing that its lead siRNA...
Army Medical University demonstrates hepatic APOE3 Christchurch gene therapy reduces Alzheimer's pathology in Neuron
Researchers at Army Medical University (Third Military Medical University) in Chongqing, China report that liver-directed delivery of the APOE3 Christchurch...
University of Washington receives USD 1.2m NIH R35 award for cardiovascular-diabetes research
The [University of Washington](https://app.allsci.com/organization/ASC-OH-0000000000030-1.0-1764853177) has received a USD 1.2 million NHLBI R35 award to investigate the lipoprotein mechanisms driving cardiovascular disease risk in youth with diabetes, reflecting sustained National Institutes of Health interest in closing the translational gap between metabolic biology and early vascular preventio
University of Virginia receives USD 1.44m NIH grant for type 1 diabetes alternative splicing research
Alternative splicing emerges as a mechanistic focus in type 1 diabetes risk research, with the University of Virginia receiving USD 1.44 million from NIDDK...
The AllSci Brief
Systematic R&D and deal news. Daily.